FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for glipizide from Apotex Corp., enabling the continued marketing of this generic antidiabetic medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)